ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0191

Patient-reported Outcomes to Assess Dyspnea in Connective Tissue Diseases, Interstitial Lung Disease and Pulmonary Hypertension, a Systematic Literature Review of Measurement Properties

Jacqueline Lemmers1, Madelon Vonk2 and Els Ende, van den3, 1Radboud University Medical Centre Nijmegen, Nijmegen, Netherlands, 2Department of Rheumatology, Radboud University Medical Center, Nijmegen, Netherlands, 3Radboudumc, Nijmegen, Netherlands

Meeting: ACR Convergence 2022

Keywords: interstitial lung disease, Outcome measures, Patient reported outcomes, pulmonary, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Patient Outcomes, Preferences, and Attitudes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: This COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN)-based systematic review aims to identify and summarize the quality of measurement properties of dyspnea-specific patient reported outcome measures (PROMS), for patients with interstitial lung disease (ILD), pulmonary hypertension (PH) or connective-tissue diseases (CTD).

Methods: A systematic literature search in PUBMED and EMBASE, was last updated in March 2022 to identify publications evaluating ≥1 measurement properties on dyspnea-specific PROMS in our target population. Based on COMIN analysis and the Grading of Recommendations Assessment Development and Evaluation (GRADE) approach, overall rating and level of evidence for identified measurement properties of included PROMS was assessed, and used to formulate recommendations.

Results: We identified 26 publications on 10 PROMS. The Dyspnea-12 (D12), EXACT-respiratory Symptoms-IPF- breathlessness subscale (ERS-IPF-B) and King’s Brief Interstitial Lung Disease Health Status Questionnaire – breathlessness and activities subscale (K-BILD-B) had high quality evidence for sufficient internal consistency, without high quality evidence of insufficient measurement properties, and can therefore be recommended for use. The University of California San Diego Shortness of Breath Questionnaire (UCSD-SOBQ) showed insufficient responsiveness in this target population. Most PROMS in this systematic review have moderate or low quality evidence on construct validity and responsiveness.

Conclusion: The K-BILD-B, despite lacking evidence on several important domains, is currently considered the best performing PROM. The UCSD-SOBQ is not recommended for use, due to high quality evidence on insufficient responsiveness in this population.

Supporting image 1


Disclosures: J. Lemmers, None; M. Vonk, Boehringer Ingelheim, Ferrer, Galapagos, Janssen, Merck/MSD, Corbus, EUSTAR; E. Ende, van den, None.

To cite this abstract in AMA style:

Lemmers J, Vonk M, Ende, van den E. Patient-reported Outcomes to Assess Dyspnea in Connective Tissue Diseases, Interstitial Lung Disease and Pulmonary Hypertension, a Systematic Literature Review of Measurement Properties [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/patient-reported-outcomes-to-assess-dyspnea-in-connective-tissue-diseases-interstitial-lung-disease-and-pulmonary-hypertension-a-systematic-literature-review-of-measurement-properties/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-outcomes-to-assess-dyspnea-in-connective-tissue-diseases-interstitial-lung-disease-and-pulmonary-hypertension-a-systematic-literature-review-of-measurement-properties/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology